| |
| |
|
| Insider
Information: |
Berkenblit Anna |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
149,064 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,575,755 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
149,064 |
|
|
| Total
Value |
$3,575,755 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunogen Inc |
IMGN |
|
2023-06-30 |
113,935 |
|
0 |
Premium* |
|
|
Surrozen Ord Shs |
SRZN |
Director |
2021-08-11 |
35,129 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMGN |
Immunogen Inc |
SVP & CHIEF MEDICAL OFFICER |
• – – |
2023-06-30 |
4 |
A |
$4.05 |
$13,219 |
D/D |
3,264 |
113,935 |
0 |
- |
|
| IMGN |
Immunogen Inc |
SVP & CHIEF MEDICAL OFFICER |
• – – |
2022-12-30 |
4 |
A |
$3.92 |
$1,709 |
D/D |
436 |
110,671 |
0 |
- |
|
| IMGN |
Immunogen Inc |
SVP & CHIEF MEDICAL OFFICER |
• – – |
2022-06-30 |
4 |
A |
$3.83 |
$11,754 |
D/D |
3,073 |
110,235 |
0 |
- |
|
| IMGN |
Immunogen Inc |
SVP & Chief Medical Officer |
• – – |
2021-12-31 |
4 |
A |
$5.60 |
$9,862 |
D/D |
1,761 |
107,162 |
0 |
- |
|
| SRZN |
Surrozen Ord Shs |
Director |
– • – |
2021-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
35,129 |
|
% |
|
| IMGN |
Immunogen Inc |
SVP & Chief Medical Officer |
• – – |
2021-06-30 |
4 |
A |
$5.52 |
$11,382 |
D/D |
2,062 |
105,401 |
0 |
- |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical Officer |
• – – |
2020-12-31 |
4 |
A |
$4.04 |
$8,900 |
D/D |
2,203 |
103,339 |
0 |
- |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical Officer |
• – – |
2020-06-30 |
4 |
A |
$3.91 |
$11,914 |
D/D |
3,047 |
101,136 |
0 |
- |
|
| IMGN |
Immunogen Inc |
SVP & Chief Medical Officer |
• – – |
2020-02-24 |
4 |
AS |
$4.99 |
$128,757 |
D/D |
(25,803) |
98,089 |
0 |
% |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical Officer |
• – – |
2019-07-01 |
4 |
A |
$1.84 |
$9,623 |
D/D |
5,230 |
123,892 |
0 |
- |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical Officer |
• – – |
2019-01-03 |
4 |
A |
$4.08 |
$10,016 |
D/D |
2,455 |
135,224 |
0 |
- |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical Officer |
• – – |
2018-10-16 |
4 |
AS |
$8.00 |
$46,808 |
D/D |
(5,851) |
132,769 |
0 |
- |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical Officer |
• – – |
2018-09-10 |
4 |
AS |
$9.46 |
$55,350 |
D/D |
(5,851) |
138,620 |
0 |
- |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical Officer |
• – – |
2018-02-22 |
4 |
AS |
$5.60 |
$92,747 |
D/D |
(16,562) |
118,662 |
0 |
- |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical Officer |
• – – |
2018-02-21 |
4 |
AS |
$10.88 |
$188,540 |
D/D |
(17,329) |
144,471 |
0 |
- |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical Officer |
• – – |
2017-09-13 |
4 |
S |
$7.00 |
$10,500 |
D/D |
(1,500) |
161,800 |
0 |
- |
|
| IMGN |
Immunogen Inc |
VP & Chief Medical OfficerOffi |
• – – |
2016-12-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,000 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
